All > Massachusetts Investigators

Scott Plotkin, MD

Massachusetts General Hospital

Boston, Massachusetts - 02114

CLINICAL TRIALS 2
CONDITIONS5
INTERVENTIONS4
SINCE2007

Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors

May 2007 - June 2011

PTC299 for Treatment of Neurofibromatosis Type 2

July 2009 - May 2011

Brain Neoplasms

Glioblastoma

Gliosarcoma

Neurofibromatoses

Neurofibromatosis 2

Radiation Therapy

Temozolomide

Zd6474

Ptc299

Learn about TrialX Patient Recruitment services

Massimo Loda, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Suzanne Shusterman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Childrens Hospital Boston, Dana-Farber Cancer Institute. Children's Hospital Boston

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana Farber / Brigham and Women's Cancer Center Dana-Farber Cancer Institute, Center for Neuro-Oncology Dana-Farber Cancer Instiute

Lewis B. Silverman, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute and Children's Hospital Dana Faber Cancer Institute, Children's Hospital, Dept. of Pediatric Oncology Children's Hospital Boston Dana-Farber Cancer Institute

Scott Plotkin, MD

Massachusetts General Hospital

Massimo Loda, MD

Suzanne Shusterman

Patrick Y. Wen, MD

Lewis B. Silverman, MD

Kay Kehoe, Coordinator

Jennifer Brown, MD

Rachel A. Freedman

Edwin P. Alyea, MD

F. Stephen Hodi, MD

Beth A. Overmoyer, MD, FACP